Thyroid hormones and diabetic nephropathy: An essential relationship to recognize

Area of Science:

• Endocrinology
• Nephrology
• Diabetology

Background:

• Abnormal thyroid hormone metabolism is frequent in type 2 diabetes mellitus (T2DM) with diabetic nephropathy (DN).
• The specific relationship between thyroid hormones and DN progression has been under-recognized in clinical practice.

Purpose of the Study:

• To investigate the association between thyroid hormone levels and clinicopathological characteristics in patients with biopsy-proven DN.
• To evaluate the impact of elevated thyroid-stimulating hormone (TSH) and reduced free triiodothyronine (FT3) on DN severity.

Main Methods:

• Collected clinical and pathological data from 146 biopsy-proven DN patients.
• Categorized patients into euthyroid, high TSH, low FT3, and combined high TSH/low FT3 groups.
• Utilized logistic regression and specialized analyses (quarterback, eight-point) to assess correlations between thyroid hormones and DN parameters.

Main Results:

• Significant differences in proteinuria and glomerular lesion severity were observed between euthyroid and high TSH groups.
• Reduced estimated glomerular filtration rate, elevated serum creatinine, and increased glomerular damage were noted in the low FT3 group compared to euthyroid.
• Patients with TSH levels of 4.54-5.67 mU/L exhibited the most severe renal pathology, with improved renal changes correlating with higher FT3 levels.

Conclusions:

• Diabetic nephropathy patients with high TSH and/or low FT3 demonstrate more severe proteinuria, renal insufficiency, and glomerular lesions.
• Findings suggest that thyroid hormone regulation could play a role in renoprotection for DN patients.
• Further research into thyroid hormone management for preventing DN progression is warranted.